Skip to main content
Caplight Logo









Vital Bio

Vital Bio

Private
TorontoHealthcare & Life Scienceshttps://vitalbio.com/

Last Round

Series A

Jul 24, 2023

Total Funding Raised

$77.44M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Vital Bio is a healthcare technology company that develops advanced diagnostic solutions, including the VitalOne point-of-care platform, to enhance the personalization, accessibility, and effectiveness of medical care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

point-of-care diagnosticsPOC testingblood testing deviceclinical laboratorymedical devicemicrofluidicsdiagnostic platformautomated blood analysislab-on-a-chipclinical workflow integrationdiagnostic consumablescomputer vision diagnosticsdecentralized diagnosticsrapid blood testinghealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vital Bio Comparables

Compare Vital Bio with similar companies based on industry and business-model similarity.

Vital Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Truvian
89%
Chronus Health
83%
Instadiagnostics, Inc.
81%

Vital Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 24, 2023
SeedOct 1, 2019

Key People

Founding team and executive leadership

Vasu Nadella

Co-Founder, CEO

Founding Team

Vital Bio Investors

Notable investors and investment history

Vital Bio investors
InvestorRounds
Forefront Venture PartnersSeries A
Inovia CapitalSeries A, Early Funding, Seed
Stanford UniversitySeries A
BrightEdgeSeries A
Northpond VenturesSeries A
NEXT VENTŪRESSeries A
Route 66 VenturesSeries A, Early Funding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 43% MoM.

  • Jul 1, 2026

    Analytical IVD instrument 'Viking' is in design transfer phase.

Vital Bio Filings

Explore SEC and related filing metadata, where available.

Vital Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vital Bio's valuation, stock price, and market status.

Is Vital Bio a public or private company?

Vital Bio is a private company.

What is the current stock price of Vital Bio?

Vital Bio is a private company, so its shares have no public market price. Caplight tracks Vital Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Vital Bio worth (valuation)?

Valuation information for Vital Bio is not publicly available.

Can I buy Vital Bio stock?

Vital Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Vital Bio's last funding round?

Vital Bio's most recent funding round was Series A on July 24, 2023.

Who are the main investors in Vital Bio?

Key investors in Vital Bio include Northpond Ventures, Leerink Transformation Partners.

Will Vital Bio IPO soon?

No public IPO plans have been announced for Vital Bio.

How can I track Vital Bio secondary market activity?

Caplight tracks bids, offers, and trades in Vital Bio's shares on secondary markets.

Firmographic Details

HeadquartersToronto
Employee Range243
Year Founded2019
Last FundingJul 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?